com/reports/c18898 ) has announced the addition
of Lung Cancer Outlook to their offering .
These late stage investigational drugs are the most discussed drugs during the
recent year.researchandmarkets .

New Survey Finds That America's 'Sweatiest Moments' are Job Related; International Hyperhidrosis Society is Raising Awareness about How Much Sweat is Too Much

studies bibliographies

(Logo: http://www.com
Fax: +353 1 4100 980

com/broadcast/21165/consumer.shtml

STORY SUMMARY:
Does your boss make you sweat? You're not alone. Sadly, the survey found that nearly 90% of
people with hyperhidrosis have experienced hurtful reactions from others who
see them sweat.org , an online support community with
information about coping with excessive sweating, and more.

studies society

This issue of Cancer Highlights studies the progress of the most
pronounced anti-cancer drugs in development for the treatment of NSCLC.
Several unfavorable results have been the reality for many drugs. But, in
contrary Eli Lilly's Alimta has clearly seen advancements. Since a phase III study evaluating
Iressa in combination with standard cytotoxic therapy failed to demonstrate a
survival advantage in advanced NSCLC compared with chemotherapy alone, the
expert panel guideline from ASCO suggest that the population best suited for
treatment with Iressa remains to be defined.
This issue of Cancer Highlights will examine the latest events of
importance for understanding the progress in NSCLC cancer therapeutics. NEW YORK,

ADDITIONAL
RESOURCES: Video, hard copy requests, contact information and
more available at
http://www. There are many effective treatment options for sweating, including
prescription antiperspirants, Botox injections and a procedure which passes an
electrical current through a water bath.

people society

com/cgi-bin/prnh/20040820/RESEARCH )
Lung cancer is the third most common malignant disease and the first
leading cause of cancer death in the western world. sweat profusely all
day, every day. This excessive sweating, a medical condition called
hyperhidrosis, can be devastating and all too often goes undiagnosed. The survey found that 83% of people who sweat all the time
don't seek the help of a doctor because they don't understand they have a real
medical condition or don't think anything can be done about it.

men studies

researchandmarkets . In the year
2002, over 800,000 people worldwide died of non-small cell lung cancer
(NSCLC). More than 200
companies have been identified that have, or have had, drugs under therapeutic
development in patients with lung cancer in one form or the other.
The most recent addition to NSCLC cancer treatments is AstraZeneca's drug
Iressa, approved May 2003 by FDA and in March 2004 in Switzerland for treating
patients whose NSCLC cancer has continued to progress despite treatment with
platinum -based and docetaxel chemotherapy.
An extensive part is focused on the recent years success/failures of the
late stage investigational cancer drugs. Giving a compiled data on the most
important events that influence and shape the potential of the top ranking
NSCLC cancer drugs to enter the market .

For more information visit
http://www.prnewswire. But what
if you sweat all the time , regardless of the circumstances?
Nearly 8 million men, women and children in the U.

society men

newscom.
According to American Cancer Society predictions, 173,770 will be
diagnosed and 160,440 people will die by lung cancer in 2004.S.
Hyperhidrosis can have devastating effects on social relationships , career
choices and mental well-being.

The International Hyperhidrosis Society is launching the "Know Sweat"
campaign to encourage people to see a dermatologist if they feel they sweat
too much.SweatHelp.

VIDEO PROVIDED BY: International Hyperhidrosis Society

bibliographies syllabi

Research and Markets: More People Die of Lung Cancer Than of Colon Breast and Prostate Cancers Combined

DUBLIN, Ireland, Research and Markets
(http://www. More people die of lung cancer than of colon , breast, and prostate
cancers combined. Of these,
approximately 30 companies are conducting phase III trials for lung cancer. During 2003 and the first quarter of 2004 approximately 850
studies have been published that are related to NSCLC.com/reports/c18898

Laura Wood
Senior Manager
Research and Markets
press@researchandmarkets. According to a recent
survey from the International Hyperhidrosis Society, a majority of people
cited job-related issues as the ones that make them sweat the most.

Visit http://www.